FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2173729 · Received July 23, 2011

Report

Report Number
2124215-2011-11026
Event Type
Malfunction
Date Received
July 23, 2011
Date of Event
June 11, 2011
Report Date
June 21, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

OUR RECORDS INDICATE THIS DEVICE REMAINS IMPLANTED. IF ADDITIONAL INFORMATION IS RECEIVED, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECEIVED AN INAPPROPRIATE SHOCK. THE PATIENT HAD A MONITOR ONLY VT-1 ZONE IN WHICH THE EPISODE STARTED IN, THEN IT ACCELERATED INTO THE VT ZONE. TECHNICAL SERVICES (TS) DISCUSSED THE BEHAVIOR OF NO DETECTION ENHANCEMENTS WHEN IN REDETECT AND OFFERED PROGRAMMING OPTIONS TO MITIGATE THE ISSUE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 58 YR 4470| 0184| T165| E110